New! Download Our FREE 2022 Psychedelics Outlook Report

"Anybody who is even thinking about investing in the psychedelic sector needs to be aware that this is a long-term investment. You need to have a five-plus-year-long time horizon here."
— James Halifax, host of the Psychedelic Investor

“There is going to be a natural filter in the sense that the (psychedelics) companies that can make it through controlled clinical trials would probably be the winners in the longer term. It all comes down to proving that in a controlled clinical trial, and I think several companies are on the right track."
— Sumant S. Kulkarni, managing director at Canaccord Genuity

"The (psychedelics) space is crowded. Look for strong differentiation and revenue-generation models."
— Dugan Selkirk, investor relations manager with Universal Ibogaine

Who We Are

The Investing News Network is a growing network of authoritative publications delivering independent,
unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety
of markets including gold, cannabis, biotech and many others. This means you read nothing but the best from
the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks
of research yourself.

At the same time, not a single word of the content we choose for you is paid for by any company or
investment advisor: We choose our content based solely on its informational and educational value to you,
the investor.

So if you are looking for a way to diversify your portfolio amidst political and financial instability, this
is the place to start. Right now.